Iambic Therapeutics files for IPO to fund cancer drugs

Investing.com· Investing.com· Sep 21, 2026 · 9:59 PM

This is a summary. Read the complete story at Investing.com below.

Nintendo Switch 2 sales plunge 41% as price hikes and memory crunch bite

Sales of Nintendo's flagship Switch 2 plunged in its fiscal second quarter after the Japanese gaming giant rolled out price hikes amid soaring memory costs.

CNBC Stocks

stocksabout 3 hours ago

IMCD third quarter earnings rise 18% to €140.2 million

Investing.com